Table 3. TCR-BV sequences identified in brain tissue, CSF cells, and sorted peripheral blood cells (PBL) from patient B by CDR3 spectratyping.
TCR-BV CDR3 sequence | Brain 05/2001 | CSF 11/2001 | CD4+ PBL 12/2001 | CD8+ PBL 12/2001 | CD38+ PBL 12/2001 |
---|---|---|---|---|---|
BV16 - C A S S - R L T D S T - T D T - BJ2.3 | (+) | - | - | + | - |
BV19 - C A S S - H P G T G S N - E Q Y - BJ2.7 | + | + | - | (+) | - |
BV20 - C A W S - A P D - N T E - BJ1.1 | (+) | - | - | (+) | - |
BV23 - C A S S - P G R A G - S P L - BJ1.6 | - | + | + | - | - |
BV24 - C A T S - R L Q G G - T G E - BJ2.2 | + | + | - | - | + |
The N-D-N regions are shown in italics, +, completely readable sequence; (+), clonal identity clearly discernible on an oligoclonal background; -, clone not identifiable by CDR3 spectratyping and/or direct sequencing. Note that the TCR sequences observed at different sites and time points were identical both at the nucleotide and amino acid levels.